Author: Paul Govern
Study examines impulsiveness in Parkinson’s disease
Nov. 17, 2022—Vanderbilt researchers are studying aspects of dopamine release and its regulation in Parkinson’s patients with and without impulsive-compulsive behaviors.
Kennedy Center seeks participants for disabilities research learning sessions
Nov. 10, 2022—In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.
Infectious Diseases Society of America honors Wright
Nov. 10, 2022—Vanderbilt's Patty Wright, MD, is one of two recipients of the 2022 Watanakunakorn Clinician Award from the Infectious Diseases Society of America.
Study explores possible drug target for neurological problems
Nov. 3, 2022—A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.
New QSRP awards program
Nov. 3, 2022—A new awards program will recognize quality and safety improvement excellence across Vanderbilt Health.
Study to search EHR for undiagnosed genetic diseases
Oct. 13, 2022—A team at Vanderbilt University Medical Center will explore computational solutions to help address the problem of missed or delayed diagnosis for patients with rare genetic diseases.
VUH adopts enhanced recovery for sarcoma surgery
Oct. 13, 2022—Vanderbilt's latest enhanced recovery after surgery clinical pathway was launched last month for adult patients receiving surgery to remove extremity soft tissue sarcomas, which are cancerous tumors that can arise in muscles, tendons, fat, blood vessels and other connective tissue.
Gene tied to childhood epilepsy
Oct. 6, 2022—Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.
Gregory inducted into Tennessee Health Care Hall of Fame
Oct. 6, 2022—Vanderbilt's David Gregory, MD, associate professor of Medicine, emeritus, is among five honorees who will be inducted Oct. 18 to the Tennessee Health Care Hall of Fame.
Paper defines AI-related competencies for health professionals
Oct. 6, 2022—Researchers at Vanderbilt University Medical Center and IBM Watson Health engaged experts from around the country in defining a set of AI-related clinical competencies for health care professionals.
Penicillin delabeling initiative expanding to more patient care areas
Sep. 29, 2022—Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.
Conference highlights REDCap’s global reach
Sep. 29, 2022—REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.
